ARIDIS PHARMACEUTICALS INC (ARDS) Earnings History & Surprises
NASDAQ:ARDS • US0403341045
0.3101 USD
+0.05 (+17.91%)
At close: Jul 18, 2023
0.2619 USD
-0.05 (-15.54%)
After Hours: 7/18/2023, 8:14:23 PM
Past quarterly earnings results for ARIDIS PHARMACEUTICALS INC (ARDS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateAug 14, 2023
Last Reported
Release DateJun 8, 2023
PeriodQ1 / 2023
EPS Reported
EPS Surprise %
Revenue Surprise %
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2023 | - | - | 1.082M | - | -8.85% | |||
| Q4 2022 | -0.60 | -0.42 | -43.47% | 34.78% | 1.213M | 314.497K | 285.70% | 22.90% |
| Q3 2022 | -0.47 | -0.17 | -171.05% | 75.77% | 399K | 7.616M | -94.76% | -22.52% |
| Q2 2022 | -0.45 | -0.06 | -635.29% | 18.18% | 292K | 10.672M | -97.26% | 784.85% |
| Q1 2022 | -0.44 | -0.52 | 15.42% | 42.86% | 1.187M | 2.04M | -41.81% | - |
| Q4 2021 | -0.92 | -0.42 | -119.99% | -55.93% | 987K | 1.938M | -49.07% | - |
| Q3 2021 | -1.94 | -0.52 | -270.51% | -198.46% | 515K | 170.003K | 202.94% | - |
| Q2 2021 | -0.55 | -0.64 | 14.07% | -17.02% | 33K | 306K | -89.22% | -96.70% |
| Q1 2021 | -0.77 | -0.63 | -22.25% | -5.48% | 102K | -100.00% | - | |
| Q4 2020 | -0.59 | -0.61 | 2.51% | - | 510K | -100.00% | - | |
| Q3 2020 | -0.65 | -0.64 | -1.47% | - | 318.75K | -100.00% | - | |
| Q2 2020 | -0.47 | -0.76 | 38.07% | - | 1M | 275.4K | 263.11% | - |
| Q1 2020 | -0.73 | -0.68 | -6.82% | - | 318.75K | -100.00% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
0
Average EPS beat (4)
-283.27%
Max EPS beat (4)
-43.47%
Min EPS beat (4)
-635.29%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
31.22%
Max Revenue beat (4)
285.70%
Min Revenue beat (4)
-97.26%
Analysis
In the last 4 quarters, ARDS has not beaten EPS estimates in any release
ARDS has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, ARDS reported -283.3% below the EPS estimates on average.
In the last 4 quarters, ARDS has beaten the revenue estimates by 31.2% on average.
ARIDIS PHARMACEUTICALS INC / ARDS Earnings FAQ
When did ARIDIS PHARMACEUTICALS INC (ARDS) report earnings last quarter?
ARIDIS PHARMACEUTICALS INC (ARDS) last reported earnings on 6/8/2023.
Did ARDS stock beat earnings estimates in the most recent quarter?
ARIDIS PHARMACEUTICALS INC (ARDS) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does ARIDIS PHARMACEUTICALS INC (ARDS) beat earnings estimates?
In the last 4 quarters, ARIDIS PHARMACEUTICALS INC (ARDS) has beaten EPS estimates in 0 out of 4 releases.